The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First report of ELUCIDATOR study: A prospective observational multicenter study on resistance mechanisms in patients with early disease progression during osimertinib.
 
Yasuyuki Mizumori
No Relationships to Disclose
 
Akihiro Tamiya
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Lilly Japan; Merck; MSD; Nihonkayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Thermo Fisher Scientific
Research Funding - AstraZeneca; BeiGene; Daiichi Sankyo/UCB Japan
 
Mitsuo Osuga
No Relationships to Disclose
 
Shun-ichi Isa
No Relationships to Disclose
 
Yoshihiko Taniguchi
Speakers' Bureau - AstraZeneca/Hong Kong; Chugai Pharma; Ono Pharmaceutical
 
Keiichi Nakamura
No Relationships to Disclose
 
Daijiro Harada
Honoraria - AstraZeneca Japan; Bristol-Myers Squibb Company; Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Towa Pharmaceutical
Research Funding - AstraZeneca Japan; Bristol-Myers Squibb Company; Chugai Pharma; Kissei Pharmaceutical; Lilly; MSD K.K.; Novartis; Pfizer; Takeda
 
Tsutomu Shinohara
No Relationships to Disclose
 
Hidetoshi Yanai
No Relationships to Disclose
 
Katsumi Nakatomi
No Relationships to Disclose
 
Masahide Oki
Speakers' Bureau - AMCO; AstraZeneca/Hong Kong; Canon Medical System; Chugai Pharma; FUJIFILM Toyama Chemistry; Kaneka Medix; Merit Medical Systems; Novartis; Olympus; Sanofi
Research Funding - Abbvie; AstraZeneca; Chugai Pharma; FUJIFILM Toyama Chemistry; GlaxoSmithKline; Janssen; MSD; Ono Pharmaceutical; PAREXEL; Pfizer; Sanofi
 
Masahide Mori
Speakers' Bureau - AstraZeneca/Hong Kong; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo Pharmaceutical; Kyowa Kirin; Lilly O.; MSD; Nihonkayaku; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Shionogi; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma; Delta-Fly Pharma; MSD; Ono Pharmaceutical
 
Tomohito Kuwako
No Relationships to Disclose
 
Koji Yamazaki
No Relationships to Disclose
 
Atsuhisa Tamura
No Relationships to Disclose
 
Masahiko Ando
Research Funding - Kyowa Kirin (Inst)
 
Yasuhiro Koh
Honoraria - Amgen; Chugai Pharma; Guardant Health; Takeda; Tosoh Corporation
Consulting or Advisory Role - Tosoh Corporation
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Takeda (Inst); Tosoh Corporation; Zeon Corporation